NEW YORK – Lucence said on Thursday that its laboratory in Palo Alto, California has received CLIA certification from the Centers for Medicaid & Medicare Services.
Known as Lucence Health in the US, the Singapore-based firm plans to quickly scale US-based testing capacity for its LiquidHallmark liquid biopsy assay.